生化科技研發業
暫不提供
暫不提供
台北市內湖區新湖二路345號6樓
CerbACT Asia is a joint venture between Cerba Research in Belgium and ACT Genomics in Taiwan, serving as an Immuno-Oncology Centre of Excellence that empowers precision medicine development and drives better patient outcomes by applying deep biomarker expertise to research and clinical development strategies. It is enabled by cutting edge technologies in Flow Cytometry, Immunohistochemistry, and PBMC/cell isolation, while functioning as a Central Laboratory in the APAC region. Working with biotech, pharma, government, and non-government organizations, our team is ready to turn precision medicine into action! 識動亞洲是位於比利時的Cerba Research及台灣的行動基因合資成立的一家位於亞太地區的中心實驗室,著力於各項生物標記的檢驗與分析,以先進的流式細胞儀技術平台、免疫化學組織染色及細胞分離,協助各生技公司、藥廠、政府及非政府組織在臨床研究及藥物開發上的進展。全體同仁並致力於將”精準醫療”從口號轉化成實際行動,以免疫腫瘤學卓越中心為目標,期望為廣大患者帶來更好的臨床結果。
CerbACT Asia is a specialty CRO that provides services to clinical trials in the following areas: Flow Cytometry, Immunohistochemistry, Cell/PBMC Isolation and Central Lab functionality such as sample accessioning, shipping and storage.
1. 休假福利:優於勞基法的休假天數 (帶薪病假、放空假等) 2. 保險福利:勞保、健保、團體綜合保險,包括壽險、重大疾病險、意外險、醫療險、癌症險等 3. 職涯發展:全球化教育訓練、健全升遷制度、在職進修補助
CerbACT Asia Opening Ceremony
Laboratory Accreditation by College of American Pathologists (CAP)